Emily Melton
Managing Partner at Threshold Ventures
Portola Valley, California
Overview
Work Experience
Founder and Managing Partner
2014 - Current
Threshold is an early-stage venture capital firm that focuses on conviction investment strategy.
Board Member
2025
VideaHealth is offers dentistAI’s software automatically detects pathologies in dental imaging, helping dentists avoid missing diseases.
Raised $26,500,000.00 from Zetta Venture Partners, Spark Capital and Pillar VC.
Board Member
2024
Investor & Board Observer
2021
Transcarent is a provider of a healthcare platform that facilitates improved outcomes and cost-effective decisions.
Raised $424,000,000.00 from 7wire Ventures, Human Capital, Memorial Hermann Health System, General Catalyst, Leaps by Bayer, Alta Partners, Ally Bridge Group, Kinnevik, Geodesic Capital and Threshold.
Board Member
2016
BetterUp develops an AI-driven platform that helps people and businesses grow personally and professionally through coaching.
Raised $570,014,699.00 from Mubadala Capital Ventures, Morningside Venture Investments, Sapphire Ventures, Wellington Management, SV Angel, Lightspeed Venture Partners, Salesforce Ventures, Plus Capital and ICONIQ Growth.
Board Member
2020
Brightline is a med-tech company that provides behavioral healthcare services for children and their families.
Raised $212,000,000.00 from Northwell Health, 7wire Ventures, Google Ventures, Boston Children's Hospital, Oak HC/FT, Blue Cross Blue Shield of Massachusetts, Threshold, Optum Ventures and Kohlberg Kravis Roberts.
Board Member
2020
Tia is a health care provider that specializes in mental health, wellness, general care, and gynecology.
Raised $132,775,000.00 from Define Ventures, Combine, Threshold, The Helm, ACME Capital, Compound, Torch Capital, Seae Ventures, Human Ventures and GingerBread Capital.
Board Member
2018
Verge Genomics uses machine learning and human genomics to accelerate drug discovery.
Raised $134,120,000.00 from Tenmile.
Board Member
2017
Imagen is a healthcare organization that provides onsite and diagnostic solutions to maximize clinical outcomes and patient satisfaction.
Raised $134,320,999.00 from Casdin Capital.
Board Member
2019